Uniting human, animal pharma/biotech strengthens fight against cancerJune 8, 2020Using a One Health approach to enhance developments for human and canine cancer treatments is central to a new manuscript, supported by World Small Animal Veterinary Association (WSAVA’s) One Health Committee (WSAVA OHC).
SPONSORED CONTENTMore life to love for patients with certain types of canine CHF. See how different formulations help dog owners manage certain types of CHF in their pets. + Learn More
Genetic enzymes may point to canine cancer preventionApril 15, 2020Certain dogs may be more susceptible than others to developing environmentally associated cancers.
$2.1 million in grants fund canine cancer researchMarch 3, 2020Early-stage lymphoma, appendicular osteosarcomas, and the detection of degenerative myelopathy are among the research topics selected to receive funding from the AKC Canine Health Foundation (CHF).
Canine officer treated for rare cancer at Texas A&MJanuary 13, 2020A surgical oncologist at Texas A&M College of Veterinary Medicine and Biomedical Sciences (CVM) is credited with saving the life of a canine officer after diagnosing the pooch with an uncommon type of tumor.
Noninvasive cancer imaging technique to help in early detectionNovember 21, 2019A new cancer imaging technique is expected to significantly improve the ability to diagnose the disease’s spread to lymph nodes in dogs with head and neck tumors.
Canine cancer screening test in the worksOctober 31, 2019Veterinarians may soon be equipped with a tool that would assist in the early detection of canine cancer.
Cat virus could be linked to feline cancerOctober 25, 2019Australian researchers believe a newly discovered feline virus might be the cause of liver cancer in cats, and that this link could lead to the development of new anti-cancer therapies.
Stereotactic radiation may offer better outcomes in nine cancersOctober 24, 2019New data suggests a specific advanced radiation treatment protocol is leading to better survival outcomes than other therapy options for at least nine tumor types. That's according to PetCure Oncology, which presented its findings at the recent Veterinary Cancer Society Annual Conference (VCS) in Houston, Tex. The pet cancer care provider says nine of the 11 tumor types it studied showed increased median survival time relative to the current body of peer-reviewed published literature for pets treated with stereotactic radiation/stereotactic radiation therapy (SRS/SRT), an advanced form of radiation therapy used in human medicine. The list of tumor types includes brain, nasal, osteosarcoma (bone tumors), mast cell, and melanoma. "We have now treated more than 3,000 pets on-protocol with radiation therapy, including more than 2,200 with stereotactic radiation," says PetCure's chief medical officer, Neal Mauldin, DVM, DACVIM (internal medicine and oncology), DACVR (radiation oncology). "The good news is that many of them are still alive and thriving, so the data is still maturing. But objective analysis of the preliminary data at this point suggests stereotactic radiation can be considered a standard of care for the treatment of many tumor types, much like it already is in human cancer treatment. This …
VCA launches 35 cancer centers across North AmericaAugust 26, 2019Pets diagnosed with cancer will now have greater access to advanced, collaborative pet cancer care. VCA Animal Hospitals says it is launching 35 VCA Pet CancerCare Centers across North America, which will be staffed by multidisciplinary oncology teams that will design individualized treatment plans using the latest in medical health-care technology. Canadian centers are also slated for Laval and Brossard near Montreal, Quebec; Ottawa, Newmarket, Oakville, and Scarborough in Ontario; Victoria in British Columbia; and Calgary, Alberta. "At VCA Pet CancerCare Centers, we are leading cancer care into a hopeful new era with longer lifespans and improved quality of life," says Zack Wright, DVM, DACVIM/Oncology, director of oncology at VCA Animal Diagnostic Clinic in Dallas, Texas. "Our dedicated oncologists across the network are committed to working with primary care veterinarians to make advanced cancer care accessible to pet owners, with the goal always being extended, high quality of life for our patients." By introducing these cancer centers, VCA hopes to provide greater accessibility of world-class treatment to help improve the quality of life for pets, as well as to cultivate open lines of communication and collaboration between oncologists, primary care veterinarians, and pet owners. According to a VCA survey, 58 …
Osteosarcoma in dogs and children genetically similarJuly 26, 2019The veterinary community might soon see advancements in the treatment of canine osteosarcoma (OS).
